[go: up one dir, main page]

FI944933L - 7-Disubstituted methyl-4-oxo-3H,5H-pyrrolo(3,2-d) pyrimidine and pharmaceutical uses and compositions containing the same - Google Patents

7-Disubstituted methyl-4-oxo-3H,5H-pyrrolo(3,2-d) pyrimidine and pharmaceutical uses and compositions containing the same Download PDF

Info

Publication number
FI944933L
FI944933L FI944933A FI944933A FI944933L FI 944933 L FI944933 L FI 944933L FI 944933 A FI944933 A FI 944933A FI 944933 A FI944933 A FI 944933A FI 944933 L FI944933 L FI 944933L
Authority
FI
Finland
Prior art keywords
pyrrolo
pyrimidine
oxo
same
compositions containing
Prior art date
Application number
FI944933A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI944933A0 (en
Inventor
Shri Niwas
Iii John A Secrist
John A Montgomery
Original Assignee
Biocryst Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biocryst Pharm Inc filed Critical Biocryst Pharm Inc
Publication of FI944933L publication Critical patent/FI944933L/en
Publication of FI944933A0 publication Critical patent/FI944933A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/32—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
    • C07C255/35—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by halogen atoms, or by nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/32—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
    • C07C255/40—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by doubly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/32—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
    • C07C255/42—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by singly-bound nitrogen atoms, not being further bound to other hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI944933A 1992-04-21 1994-10-20 7-substituted methyl-4-oxo-3H, 5H-pyrrolo (3,2-d) pyrimidine and pharmaceutical uses and compositions containing the same FI944933A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US87144192A 1992-04-21 1992-04-21
PCT/US1993/002841 WO1993021187A1 (en) 1992-04-21 1993-03-25 7-DISUBSTITUTED-METHYL-4-OXO-3H^_,5H^_-PYRROLO[3,2-d^_]PYRIMIDINE AND PHARMACEUTICAL USES AND COMPOSITIONS CONTAINING THE SAME

Publications (2)

Publication Number Publication Date
FI944933L true FI944933L (en) 1994-10-20
FI944933A0 FI944933A0 (en) 1994-10-20

Family

ID=25357439

Family Applications (1)

Application Number Title Priority Date Filing Date
FI944933A FI944933A0 (en) 1992-04-21 1994-10-20 7-substituted methyl-4-oxo-3H, 5H-pyrrolo (3,2-d) pyrimidine and pharmaceutical uses and compositions containing the same

Country Status (10)

Country Link
EP (1) EP0638080A4 (en)
JP (1) JPH07507062A (en)
KR (1) KR950701335A (en)
AU (1) AU4276693A (en)
CA (1) CA2133346A1 (en)
FI (1) FI944933A0 (en)
HU (1) HUT71559A (en)
NO (1) NO303637B1 (en)
RU (1) RU94046387A (en)
WO (1) WO1993021187A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE78999A1 (en) * 1997-05-29 1999-09-08 Novartis Ag 2-AMINO-7- (2-HYDROXYETHYL 1-SUBSTITUTED) -3.5-DIHYDROPYROLLE [3,2-D] PIRIMIDIN-4 ONAS
US6355244B1 (en) 1997-11-17 2002-03-12 University Of Kentucky Research Foundation Methods and compositions for the treatment of psoriasis
US6174888B1 (en) 1998-05-28 2001-01-16 Novartis Ag 2-amino-7-(1-substituted-2-hydroxyethyl)-3,5-dihydropyrrolo[3,2-D]pyrimidin-4-ones
GB0215392D0 (en) * 2002-07-03 2002-08-14 Glaxo Group Ltd Chemical compounds
US7557113B2 (en) 2003-08-26 2009-07-07 Teijin Pharma Limited Substituted pyrrolo[3,2-d]pyrimidine derivatives
WO2005019219A1 (en) * 2003-08-26 2005-03-03 Teijin Pharma Limited Pyrrolopyrimidinone derivative
MY140748A (en) 2004-12-06 2010-01-15 Astrazeneca Ab Novel pyrrolo [3,2-d] pyrimidin-4-one derivatives and their use in therapy
US7763257B2 (en) 2004-12-09 2010-07-27 Christina Juneau Compositions comprising transforming growth factor (TGF)-β1 and TGF-β2 in admixture of proteins obtained from dairy products
EP2225226B1 (en) 2007-12-26 2016-08-17 Critical Outcome Technologies, Inc. Compounds and their use in a method for treatment of cancer
WO2010006438A1 (en) 2008-07-17 2010-01-21 Critical Outcome Technologies Inc. Thiosemicarbazone inhibitor compounds and cancer treatment methods
CA2999435A1 (en) 2010-04-01 2011-10-06 Critical Outcome Technologies Inc. Compounds and method for treatment of hiv

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2072123C (en) * 1989-10-31 2001-06-12 John A. Secrist, Iii Inhibitors of purine nucleoside phosphorylase
US5189039A (en) * 1989-11-29 1993-02-23 Biocryst, Inc. 7-disubstituted-methyl-4-oxo-3H,5H-pyrrolo[3,2d]pyrimidine and pharmaceutical uses and compositions containing the same

Also Published As

Publication number Publication date
NO943988D0 (en) 1994-10-20
JPH07507062A (en) 1995-08-03
HUT71559A (en) 1995-12-28
EP0638080A4 (en) 1995-08-23
NO943988L (en) 1994-10-20
HU9403021D0 (en) 1994-12-28
FI944933A0 (en) 1994-10-20
KR950701335A (en) 1995-03-23
EP0638080A1 (en) 1995-02-15
AU4276693A (en) 1993-11-18
CA2133346A1 (en) 1993-10-28
WO1993021187A1 (en) 1993-10-28
NO303637B1 (en) 1998-08-10
RU94046387A (en) 1996-09-27

Similar Documents

Publication Publication Date Title
IL106431A0 (en) Aminediol derivatives and pharmaceutical compositions containing the same
IL106927A0 (en) Sulfonamide derivatives and pharmaceutical compositions containing the same
DE69325333D1 (en) Antiviral composition
PH25932A (en) Adenosine derivatives and pharmaceutical compositions containing the same
IL106624A0 (en) Asymmetrically substituted xanthines,their preparation and pharmaceutical compositions containing them
IL110743A0 (en) Heterocyclic compounds and pharmaceutical compositions containing the same
PT589843E (en) PHARMACEUTICAL COMPOSITIONS CONTAINING CYCLOSPORTS
PH30439A (en) 3,4-Dihydro-2h-1,4-benz-oxazine derivatives and pharmaceutical compositions containing the same
IL110988A0 (en) 4-arylamino-benzopyran derivatives and pharmaceutical compositions containing the same
NZ236625A (en) Pyrimidine derivatives and pharmaceutical compositions
PH27460A (en) Pyrimidine derivatives and herbicidal composition containing the same
IL94821A0 (en) Monosaccharide compounds and pharmaceutical compositions containing the same
GR862456B (en) 2-substituted-e-fused-(1,2,4) triazolo -(1,5-c)pyrimidines pharmaceutical compositions and uses thereof
PH21540A (en) Cholecalciferol derivatives and pharmaceutical compositions containing the same
FI944933L (en) 7-Disubstituted methyl-4-oxo-3H,5H-pyrrolo(3,2-d) pyrimidine and pharmaceutical uses and compositions containing the same
DE4294862T1 (en) Pharmaceutical composition
IL110509A0 (en) Pyrimido pyrimidine compounds, their preparation and pharmaceutical compositions containing them
ZA941088B (en) Substituted ketophosphonates the processes for their preparation and pharmaceutical compositions containing them
EP0180190A3 (en) 3,4-dihydrobenzopyran compounds and pharmaceutical composition containing the same
IL89376A0 (en) Substituted pyrimidines,their preparation and pharmaceutical compositions containing them
HUP9903526A3 (en) Pyrimidine derivatives and pharmaceutical compositions containing the same
GB2216794B (en) Pharmaceuticals compositions
PH21779A (en) Sulfonomidines and pharmaceutical compositions containing the same
IL88854A (en) Pyrimidine and purine 1,2-butadiene-4-ol derivatives and pharmaceutical compositions containing the same
FI934387A0 (en) 3-SUBSTITUTES 2-OXI-INDOL-1-CARBOXIAMIDE PHARMACEUTICAL COMPOSITION

Legal Events

Date Code Title Description
FD Application lapsed